The role of XRCC1 polymorphisms in base excision repair of etheno-DNA adducts in French vinyl chloride workers

International Journal of Occupational Medicine and Environmental Health

Volumn 19, Issue 1, 2006, Pages 45-52

  Li, Yongliang ^a   Marion, Marie Jeanne ^b   Zipprich, Jennifer ^a   Freyer, Greg ^a   Santella, Regina M ^a   Kanki, Chisaka ^a   Brandt Rauf, Paul W ^a  

^a Columbia University ^*  (United States)

^b INSERM   (France)

Author keywords

Base excision repair; DNA adducts; Gene environment interaction; Mutations

Indexed keywords

BIOLOGICAL MARKER; RAS PROTEIN; VINYL CHLORIDE;

ALLELE; ARTICLE; CELL CULTURE; CIGARETTE SMOKING; CODON; COHORT ANALYSIS; CONTROLLED STUDY; DNA ADDUCT; DNA POLYMORPHISM; DRINKING BEHAVIOR; ENZYME LINKED IMMUNOSORBENT ASSAY; EXCISION REPAIR; FLUORESCENCE POLARIZATION; FRANCE; GENOTYPE; HOMOZYGOSITY; HUMAN; HUMAN EXPERIMENT; INDUSTRIAL WORKER; LYMPHOBLAST; MARKER GENE; OCCUPATIONAL EXPOSURE; POLYMERASE CHAIN REACTION; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; WILD TYPE; XRCC1 GENE;

EID: 33646491878     PISSN: 12321087     EISSN: None     Source Type: Journal    
DOI: 10.2478/v10001-006-0006-9     Document Type: Article

References (32)

1. Agency for Toxic Substances and Disease Registry, 1997. Toxicological Profile for Vinyl Chloride. Atlanta: US Department of Health and Human Services; 1997.
2. Marion MJ, Froment O, Trepo C. Activation of Ki-ras gene by point mutation in human liver angiosarcoma associated with vinyl chloride exposure. Mol Carcinogenesis 1991;4:450-4.
3. Hollstein M, Marion MJ, Lehman T, Welsh J, Harris CC, Martel-Planche G, et al. P53 mutations at A:T base pairs in angiosarcomas of vinyl chloride-exposed factory workers. Carcinogenesis 1994;15:1-3.
4. Smith SJ, Li Y, Whitley R, Marion MJ, Partilo S, Carney WP, et al. Molecular epidemiology of p53 protein mutations in workers exposed to vinyl chloride. Am J Epidemiol 1998;147:302-8.
5. Li Y, Marion MJ, Asherova M, Coulibaly D, Smith SJ, Do T, et al. Mutant p21ras in vinyl chloride-exposed workers. Biomarkers 1998;6:433-9.
6. Li Y, Marion MJ, Rundle A, Brandt-Rauf PW. A common polymorphism in XRCC1 as a biomarker of susceptibility for chemically induced genetic damage. Biomarkers 2003;8:408-14.
7. Lindahl T, Wood RD. Quality control by DNA repair. Science 1999;286:1897-905.
8. Goode EL, Ulrich CM, Potter JD. Polymorphisms in DNA repair genes and association with cancer risk. Cancer Epidemiol Biomarkers Prev 2002;11:1513-30.
9. Lunn RM, Langlois RG, Hsieh LL, Thompson CC, Bell DA. XRCC1 polymorphism: effects on aflatoxin B1-DNA adducts and glycophorin A variant frequency. Cancer Res 1999;59:2557-61.
10. Shen J, Gammon MD, Terry MB, Wang L, Wang Q, Zhang F, et al. Polymorphisms in XRCC1 modify the association between polycyclic aromatic hydrocarbon-DNA adducts, cigarette smoking, dietary antioxidants, and breast cancer risk. Cancer Epidemiol Biomarkers Prev 2005;14:336-42.
11. Young TL, Santella RM. Development of techniques to monitor for exposure to vinyl chloride: monoclonal antibodies to ethenoadenosine and ethenocytidine. Carcinogenesis 1988;9:589-92.
12. Wong RH, Du CL, Wang JD, Chan CC, Luo JC, Cheng TJ. XRCC1 and CYP2E1 polymorphisms as susceptibility factors of plasma mutant p53 protein and anti-p53 antibody expression in vinyl chloride monomer exposed polyvinylchloride workers. Cancer Epidemiol Biomarkers Prev 2002;11:475-82.
13. Dosanjh MK, Chenna A, Kim E, Fraenkel-Conrat H, Samson L, Singer B. All four cyclic adducts formed in DNA by the vinyl chloride metabolite chloroacetaldehyde are released by a human DNA glycosylase. Proc Natl Acad Sci USA 1994;91:1024-8.
14. Marintchev A, Robertson A, Dimitriadis EK, Prasad R, Wilson SH, Mullen GP. Domain specific interaction in the XRCC1-DNA polymerase beta complex. Nucleic Acids Res 2000;28:2049-59.
15. Bhattacharyya N, Banerjee S. A novel role of XRCC1 in the functions of a DNA polymerase beta variant. Biochem 2001;40:9005-13.
16. Schreiber V, Ame JC, Polle P, Schultz I, Rinaldi B, Fraulob V, et al. Poly(ADP-ribose)polymerase-2 (PARP-2) is required for efficient base excision DNA repair in association with PARP-1 and XRCC1. J Biol Chem 2002;277:23028-36.
17. Vidal AE, Boiteux S, Hickson ID, Radicella JP. XRCC1 coordinates the initial and late stages of DNA abasic site repair through protein-protein interactions. EMBO J 2001;20:6530-9.
18. Xing D, Qi J, Miao X, Lu W, Tan W, Lin D. Polymorphisms of DNA repair genes XRCC1 and XPD and their associations with risk of esophageal squamous cell carcinoma in a Chinese population. Int J Cancer 2002;100:600-5.
19. Shen H, Xu Y, Qian Y, Yu R, Qin Y, Zhou L, et al. Polymorphisms of the DNA repair gene XRCC1 and risk of gastric cancer in the Chinese population. Int J Cancer 2000;88:601-6.
20. Abdel-Rahman SZ, Soliman AS, Bondy ML, Omar S, El-Badawy SA, Khaled HM, et al. Inheritance of the 194Trp and the 399Gln variant alleles of the DNA repair gene XRCC1 are associated with increased risk of early onset colo-rectal carcinoma in Egypt. Cancer Lett 2000;159:79-86.
21. Ratnasinghe D, Yao SX, Tangrea JA, Qiao YC, Anderson MR, Barrett MJ, et al. Polymorphisms of DNA repair gene XRCC1 and lung cancer risk. Cancer Epidemiol Biomarkers Prev 2001;10:119-23.
22. Chen S, Tang D, Xue K, Xu L, Ma G, Hsu Y, et al. DNA repair gene XRCC1 and XPD polymorphisms and risk of lung cancer in a Chinese population. Carcinogenesis 2002;23:1321-5.
23. Kim SU, Park SK, Yoo KS, Yoon KS, Choi JY, Seo JS, et al. XRCC1 genetic polymorphism and breast cancer risk. Pharmacogenetics 2002;12:335-8.
24. Lee JM, Lee YC, Yang PW, Luh SP, Lee CJ, Chen CJ, et al. Genetic polymorphisms of XRCC1 and risk of esophageal cancer. Int J Cancer 2001;95:240-6.
25. Stern MC, Umbach DM, van Gils CH, Lunn RM, Taylor JA. DNA repair gene XRCC1 polymorphisms, smoking, and bladder cancer risk. Cancer Epidemiol Biomarkers Prev 2001;10:125-31.
26. Nelson HH, Kelsey KT, Moh LA, Karagas MR. The XRCC1 Arg399Gln polymorphism, sunburn, and non-melanoma skin cancer: evidence of gene-environment interaction. Cancer Res 2002;62:152-55.
27. Matullo G, Guarrera S, Carturan S, Peluso M, Malaveille C, Davico L, et al. DNA repair gene polymorphisms, bulky DNA adducts in white blood cells and bladder cancer in a case-control study. Int J Cancer 2001;92:562-67.
28. Pastorelli R, Cerri A, Mezzetti M, Consonni E, Airoldi L. Effect of DNA repair gene polymorphisms on BPDE-DNA adducts in human lymphocytes. Int J Cancer 2002;100:9-13.
29. Lei YC, Hwang SJ, Chang CC, Kuo HW, Luo JC, Chang MJ, et al. Effects on sister chromatid exchange frequency of polymorphisms in DNA repair gene XRCC1 in smokers. Mutation Res 2002;519:93-101.
30. Qiao Y, Spitz MR, Shen H, Guo Z, Shete S, Hedayati M, et al. Modulation of repair of ultraviolet damage in the host-cell reactivation assay by polymorphic XPC and XPD/ERCC genotypes. Carcinogenesis 2002;23:295-9.
31. Hu JJ, Smith TR, Miller MS, Mohrenweiser HW, Golden A, Case LD. Amino acid substitution variants of APE1 and XRCC1 genes associated with ionizing radiation sensitivity. Carcinogenesis 201;22:917-22.
32. Abdel-Rahman SZ, El-Zein RA. The 399Gln polymorphism in the DNA repair gene XRCC1 modulates the genotoxic response induced in human lymphocytes by the tobacco-specific nitrosamine NNK. Cancer Lett 2000;159:63-71.